Cargando…
Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease
Immunosuppression in aqueous-deficient dry eye disease (ADDE) is required not only to improve the symptoms and signs but also to prevent further progression of the disease and its sight-threatening sequelae. This immunomodulation can be achieved through topical and/or systemic medications, and the c...
Autores principales: | Kate, Anahita, Shanbhag, Swapna S, Donthineni, Pragnya R, Amescua, Guillermo, Quinones, Victor L Perez, Basu, Sayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276741/ https://www.ncbi.nlm.nih.gov/pubmed/37026249 http://dx.doi.org/10.4103/IJO.IJO_2818_22 |
Ejemplares similares
-
Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management
por: Donthineni, Pragnya R, et al.
Publicado: (2023) -
An Evidence-Based Strategic Approach to Prevention and Treatment of Dry Eye Disease, a Modern Global Epidemic
por: Donthineni, Pragnya R., et al.
Publicado: (2021) -
Cataract Surgery in Dry Eye Disease: Visual Outcomes and Complications
por: Donthineni, Pragnya R., et al.
Publicado: (2020) -
A case series of ocular involvement in bullous pemphigoid: clinical features, management, and outcomes
por: Kate, Anahita, et al.
Publicado: (2022) -
Tear film microbiome in Sjogren’s and non-Sjogren’s aqueous deficiency dry eye
por: Pal, Spandita, et al.
Publicado: (2023)